New nasal light therapy shows promise in preventing ICU infections
NCT ID NCT06867458
First seen Mar 09, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This pilot study tested a new method to prevent serious infections like pneumonia in 227 intensive care unit (ICU) patients. The treatment uses a light-activated gel applied inside the nose to kill harmful bacteria. The main goal was to see if a larger study is possible and to gather early data on whether this approach can reduce hospital-acquired infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED PNEUMONIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Royal Columbian Hospital
New Westminster, British Columbia, V3L 3W7, Canada
Conditions
Explore the condition pages connected to this study.